[Kazan]

The problem with that is this:

India is a major supplier of pharmaceuticals, particularly generic drugs, to the United States. Approximately 47% of all generic prescriptions in the US are filled by Indian companies. This significant supply contributes to billions of dollars in savings for the US healthcare system. However, recent discussions about reciprocal tariffs could potentially impact this trade relationship.

[brent13a]

India is a major supplier of pharmaceuticals, particularly generic drugs, to the United States. Approximately 47% of all generic prescriptions in the US are filled by Indian companies. This significant supply contributes to billions of dollars in savings for the US healthcare system. However, recent discussions about reciprocal tariffs could potentially impact this trade relationship.

So theres no option for billionaires to use their capital to build pharmaceutical manufacturing in the US? It's either stick with India or nothing?